Article

FDA Imposters

Patients already have enough to worry about without now having to worry about this.

On December 29, 2009, the US Food and Drug Administration (FDA) issued a public warning about people purporting to be from the FDA who contact patients who have ordered medications online or via a phone order. The FDA imposters tell these patients that their purchases are illegal and they must pay fines, usually by wire transfer to locations outside the US. The FDA notes that some of the patients who refused to pay the fine or asked questions about the legality of online or phone transactions to purchase medications were threatened with arrest and other legal actions. In some cases, the FDA imposters not only obtained patients' phone numbers and other contact information, but also obtained their credit card information and made unauthorized purchases.

The FDA notes that impersonating an official from the FDA violates federal law. Although it seems obvious that patients should know that the FDA would never threaten legal action (let alone call patients), apparently some patients have believed the FDA imposters.

Patients can be directed to the FDA Office of Criminal Investigations Metro Washington Field Office at (800) 521-5783 to report suspected FDA imposters. Also, patients and the public need to know that there are imposters of all sorts out there--not only the FDA but also the CIA, FBI, etc.

Related Videos
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
© 2024 MJH Life Sciences

All rights reserved.